CLAREMONT, CA--(Marketwired - Jan 29, 2016) - Kiwa Bio-Tech Products Group Corporation (OTC PINK: KWBT) reported today that it has signed a strategic cooperation agreement with Zhongnan Commodity E-Commerce Co., Ltd. Hunan, China. Specifically, the parties have agreed that Kiwa's fertilizer products and agricultural products will be sold on the e-platform of Zhongnan Commodity E-Commerce Company to Zhongnan's customers. In addition, both companies intend to cooperate in the development of agricultural sales through e-business applications. Although no commitments were issued, the parties also discussed a potential equity participation in Kiwa.

"The development of an e-business platform for the sales of Kiwa's fertilizer and agricultural products is an important element of Kiwa's business strategy," said Kiwa's CEO, Jimmy Zhou. "The agreement with Zhongnan gives Kiwa a close working relationship with an important e-commerce business enterprise run by China's largest state-owned agricultural enterprise, China CO-OP Group. This will provide the Company with a solid opportunity to enlarge its share of the fertilizer and agricultural market in China."

About Kiwa Bio-Tech Products Group Corporation

We develop, manufacture, distribute and market innovative, cost-effective and eco-friendly bio-technological products for agriculture. Our main product groups are bio-fertilizer, biologically enhanced livestock feed. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. Our businesses include bio-fertilizer and bio-enhanced feed.

Kiwa's strategy is to implement increased visibility for marketing Kiwa's current bio-fertilizer products, together with the development of a "green agriculture" safe food platform in China. Our goal is to build market penetration for our Kiwa brand in China's trillion dollar "green" agricultural produce market.

For more information on Kiwa and its products, please refer to the Company's website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.